| Literature DB >> 31991544 |
Bo-Rong Peng1,2,3, Kuei-Hung Lai4, You-Ying Chen3,5, Jui-Hsin Su3,6, Yusheng M Huang7, Yu-Hsin Chen3, Mei-Chin Lu3,6, Steve Sheng-Fa Yu2,8, Chang-Yih Duh1,5, Ping-Jyun Sung3,5,6,9,10.
Abstract
In the current study, an NMR spectroscopic pattern-based procedure for probing scalarane derivatives was performed and four new 24-homoscalaranes, lendenfeldaranes A-D (1- 4), along with three known compounds, 12α-acetoxy-22-hydroxy-24-methyl-24-oxoscalar-16-en- 25-al (5), felixin F (6), and 24-methyl-12,24,25-trioxoscalar-16-en-22-oic acid (7) were isolated from the sponge Lendenfeldia sp. The structures of scalaranes 1-7 were elucidated on the basis of spectroscopic analysis. Scalaranes 1-7 were further evaluated for their cytotoxicity toward a series of human cancer cell lines and the results suggested that 5 and 7 dominated in the anti- proliferative activity of the extract. The 18-aldehyde functionality was found to play a key role in their activity.Entities:
Keywords: Lendenfeldia; anti-proliferation; scalarane; sesterterpenoid
Year: 2020 PMID: 31991544 PMCID: PMC7074534 DOI: 10.3390/md18020076
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1The structures of lendenfeldaranes A–D (1–4), 12α-acetoxy-22-hydroxy-24-methyl-24-oxo- scalar-16-en-25-al (5), felixin F (6), and 24-methyl-12,24,25-trioxoscalar-16-en-22-oic acid (7).
The 1H and 13C NMR data for 24-homoscalaranes 1 and 2 (CDCl3).
| C/H | 1 | 2 | ||
|---|---|---|---|---|
| δH ( | δC Multiple b | δH ( | δC Multiple d | |
| 1 | 2.12 m; 0.48 ddd (12.8, 12.8, 3.2) | 34.4, CH2 | 2.13 m; 0.80 m | 33.8, CH2 |
| 2 | 1.50 m | 17.8, CH2 | 1.44 m; 1.65 m | 17.9, CH2 |
| 3 | 1.19 m; 1.43 m | 41.6, CH2 | 1.18 m; 1.43 m | 41.4, CH2 |
| 4 | 33.0, C | 33.0, C | ||
| 5 | 0.94 m | 56.8, CH | 0.95 br d (12.6) | 56.8, CH |
| 6 | 1.43 m | 18.3, CH2 | 1.53 m | 18.2, CH2 |
| 7 | 1.03 m; 1.82 ddd (12.8, 3.2, 3.2) | 42.2, CH2 | 0.96 m; 1.91 ddd (13.2, 3.6, 3.6) | 42.1, CH2 |
| 8 | 37.8, C | 38.7, C | ||
| 9 | 1.50 m | 49.3, CH | 1.26 m | 62.8, CH |
| 10 | 41.7, C | 42.8, C | ||
| 11 | 2.07 m | 24.9, CH2 | 2.62 dd (12.6, 1.8); 3.34 dd (14.4, 12.6) | 39.0, CH2 |
| 12 | 4.77 br s | 75.7, CH | 221.9, C | |
| 13 | 38.9, C | 52.8, C | ||
| 14 | 1.31 m | 52.2, CH | 1.21 m | 58.0, CH |
| 15 | 2.27 m | 23.3, CH2 | 1.65 m; 1.94 ddd (12.6, 4.2, 1.8) | 30.1, CH2 |
| 16 | 6.90 br s | 139.7, CH | 3.53 ddd (10.8, 10.8, 4.8) | 72.7, CH |
| 17 | 137.9, C | 3.22 dd (12.0, 10.8) | 54.8, CH | |
| 18 | 3.79 br s | 48.0, CH | 3.18 d (12.0) | 51.3, CH |
| 19 | 0.75 s | 21.9, CH3 | 0.76 s | 21.7, CH3 |
| 20 | 0.86 s | 33.8, CH3 | 0.87 s | 33.7, CH3 |
| 21 | 1.16 s | 16.1, CH3 | 1.30 s | 16.4, CH3 |
| 22 | 3.85 d (11.6); 4.02 d (11.6) | 62.9, CH2 | 3.93 dd (11.4, 1.2); 4.08 d (11.4) | 62.7, CH2 |
| 23 | 0.96 s | 15.5, CH3 | 1.34 s | 15.3, CH3 |
| 24 | 199.3, C | 212.6, C | ||
| 25 | 175.1, C | 172.4, C | ||
| 26 | 2.29 s | 25.3, CH3 | 2.40 s | 33.4, CH |
| OAc-12 | 170.4, C | |||
| 2.14 s | 21.5, CH3 | |||
a 400 MHz. b 100 MHz. c 600 MHz. d 150 MHz.
Figure 2The key COSY correlations () and heteronuclear multiple bond correlation (HMBC) () of 1–4.
Figure 3The selected NOESY correlations () of 1–4.
The 1H and 13C NMR data for 24-homoscalaranes 3 and 4 (CDCl3).
| C/H | 3 | 4 | ||
|---|---|---|---|---|
| δH ( | δC Multiple b | δH ( | δC Multiple d | |
| 1 | 2.16 m; 0.80 m | 34.0, CH2 | 2.01 m; 0.52 ddd (13.8, 13.8, 3.0) | 34.7, CH2 |
| 2 | 1.63 m | 18.4, CH2 | 1.63 m | 18.2, CH2 |
| 3 | 1.18 m; 1.43 m | 41.7, CH2 | 1.15 ddd (9.0, 9.0, 4.2); 1.43 m | 41.5, CH2 |
| 4 | 33.0, C | 33.0, C | ||
| 5 | 1.05 m | 56.8, CH | 1.01 dd (13.8, 3.6) | 57.1, CH |
| 6 | 1.56 m; 1.91 m | 16.9, CH2 | 1.56 m; 1.93 m | 17.0, CH2 |
| 7 | 1.10 m; 1.89 m | 42.0, CH2 | 1.11 ddd (12.0, 12.0, 4.2); 1.92 m | 41.9, CH2 |
| 8 | 37.6, C | 37.5, C | ||
| 9 | 1.56 m | 52.3, CH | 1.26 m | 53.2, CH |
| 10 | 41.8, C | 40.2, C | ||
| 11 | 1.89 m; 2.18 m | 27.1, CH2 | 1.99 m; 2.20 m | 23.3, CH2 |
| 12 | 4.60 br s | 69.9, CH | 5.54 t (3.0) | 73.8, CH |
| 13 | 40.2, C | 38.4, C | ||
| 14 | 1.60 m | 50.0, CH | 1.55 m | 51.2, CH |
| 15 | 2.18 m; 2.35 m | 24.1, CH2 | 2.23 m; 2.39 m | 24.0, CH2 |
| 16 | 1.46 m; 1.56 m | 18.0, CH2 | 1.60 m | 18.0, CH2 |
| 17 | 165.2, C | 163.6, C | ||
| 18 | 133.5, C | 132.6, C | ||
| 19 | 0.78 s | 21.8, CH3 | 0.83 s | 21.9, CH3 |
| 20 | 0.86 s | 33.9, CH3 | 0.89 s | 33.7, CH3 |
| 21 | 1.08 s | 16.3, CH3 | 0.98 s | 16.4, CH3 |
| 22 | 3.92 d (11.5); 4.05 d (11.5) | 63.0, CH2 | 4.15 dd (12.0, 1.2); 4.58 d (12.0) | 64.7, CH2 |
| 23 | 1.13 s | 21.7, CH3 | 1.19 s | 21.3, CH3 |
| 24 | 4.79 q (6.5) | 78.2, CH | 4.78 q (6.0) | 77.7, CH |
| 25 | 172.6, C | 171.1, C | ||
| 26 | 1.37 d (6.5) | 18.5, CH3 | 1.36 d (6.0) | 18.6, CH3 |
| OAc-12 | 169.9, C | |||
| 1.97 s | 21.2, CH3 | |||
| OAc-22 | 170.9, C | |||
| 2.07 s | 21.2, CH3 | |||
a 500 MHz. b 125 MHz. c 600 MHz. d 150 MHz.
Figure 4The 1H and 13C NMR chemical shifts in the methyl group in the α,β-unsaturated-γ-lactone moiety in phyllactones A and B and lendenfeldaranes C (3) and D (4).
The anti-proliferative effects of scalaranes 1–7.
| Compound | Cell lines IC50 (μM) | |||
|---|---|---|---|---|
| MOLT-4 | K-562 | U-937 | SUP-T1 | |
| 1 | 39.54 | NA | NA | 33.02 |
| 2 | 34.93 | NA | NA | NA |
| 3 | 6.31 | 11.69 | 5.74 | 9.00 |
| 4 | 29.83 | NA | NA | NA |
| 5 | 0.31 | 3.04 | 2.35 | 5.90 |
| 6 | 5.67 | 9.71 | 6.97 | 12.33 |
| 7 | 1.49 | 1.04 | 5.88 | 7.49 |
| Doxorubicin a | 0.02 | 0.13 | 0.04 | 0.09 |
a Doxorubicin was used as a positive control; NA: not active at 20 μg/mL for 72 h.